NCT06494085

Brief Summary

Pressure support ventilation (PSV) is used to assist the breathing of the intubated patient with some pressure from the ventilator. This support aims at avoiding excessive inspiratory effort, while ensuring a certain degree of training of the patient's inspiratory muscle. Avoiding both minimal and excessive assistance is thus important for the optimal care of the intubated patient ensuring a lung and diaphragm protective ventilation with the goal to liberate the patient from the ventilator as soon as possible. Recently pressure-muscle-index (PMI), an index of inspiratory effort easy to be measured on the ventilator screen, has been proposed to avoid excessive assistance in PSV. This will be the first prospective study testing the effects of setting pressure support based on PMI to avoid excessive assistance on patients recovering from acute lung injury (acute hypoxemic respiratory failure).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 10, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 4, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

May 20, 2025

Status Verified

August 1, 2024

Enrollment Period

1.4 years

First QC Date

July 2, 2024

Last Update Submit

May 15, 2025

Conditions

Keywords

Mechanical VentilationIntensive Care UnitPendelluftPressure Support Ventilation

Outcome Measures

Primary Outcomes (2)

  • Inspiratory Occlusion

    To investigate the role of the inspiratory occlusion as a diagnostic tool to understand the patient's desired tidal volume and minute ventilation in Pressure Support Ventilation (PSV),

    60 minutes

  • Pressure Muscle Index (PMI)

    To investigate the role of a PMI\>0 strategy to avoid over-assistance in Pressure Support Ventilation

    60 minutes

Secondary Outcomes (2)

  • Pendelluft

    60 minutes

  • Lung and Diaphragm Protective Ventilation

    60 minutes

Interventions

First, for each patient enrolled we will perform inspiratory and expiratory occlusions - routinely performed diagnostic maneuvers to measure patient's breathing effort - at the clinically set level of breathing assistance by the mechanical ventilator. Importantly, we will measure pressure-muscle-index (PMI). Second, we will set the level of assistance (i.e. pressure support, PS) in order to make PMI=0. The PS level at which PMI=0 (PS PMI=0) will be used as reference for the study protocol. After 5 minutes at PS PMI=0 we will perform inspiratory and expiratory occlusions.

3 steps of PS above (+2, +4, +6 cmH2O) and 3 below (-2, -4, -6 cmH2O) PSPMI=0 done in a randomized order (sequence in envelopes opened blindly by the investigators). Each step will last ≤5 minutes if poorly tolerated (see tolerance rule in description). At the end of each step we will perform 1 inspiratory occlusion and 3 expiratory occlusions. Each of the expiratory occlusion will be separated by 30 seconds in order to restore the patient's breathing pattern. We will resume a 3-minutes clinical PS in between each step to minimize changes in PaCO2. If not yet comprised by the study steps each patient will undergo an adjunctive 5 minutes step at PS 0 (zero) cmH2O.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The Study population will include patients mechanically ventilated in the St. Michael's Intensive Care Unit. Patients who are younger than 18 years of age will be excluded from this study on the basis that the ICUs at St. Michael's Hospital are intended for adults; individuals aged less than 18 years are rarely, if ever, admitted.

You may qualify if:

  • \>18 y.o.
  • Invasively ventilated in Intensive Care Unit.
  • Diagnosed with acute hypoxemic respiratory failure (P/F\<300 mmHg).
  • Breathing on pressure support ventilation.

You may not qualify if:

  • \<18 y.o.
  • Contraindication for Electrical Impedence Tomography monitoring (e.g. pacemaker, burns, or - wounds limiting electrode placement).
  • Severe and previously diagnosed neurological and neuromuscular disease.
  • Psychomotor agitation (Sedation Agitation Scale \> 4).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

RECRUITING

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Laurent Brochard

    Unity Health Toronto - St. Michael's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laurent Brochard, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2024

First Posted

July 10, 2024

Study Start

October 4, 2024

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

May 20, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations